Global Gene Therapies for Cancer Treatment Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Gene Therapies for Cancer Treatment market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Gene Therapies for Cancer Treatment market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Gene therapies for cancer treatment involve the introduction or modification of genetic material within a patient＇s cells to target and combat cancer. This innovative approach aims to address underlying genetic abnormalities responsible for the development and progression of cancer. Various strategies are employed, including introducing therapeutic genes, modifying existing genes, or utilizing gene editing technologies to enhance the body＇s ability to recognize and eliminate cancer cells. One prominent example involves using viral vectors to deliver therapeutic genes that instruct the immune system to recognize and attack cancer cells specifically. CAR-T cell therapy is a notable gene therapy for certain blood cancers, where a patient＇s T cells are engineered to express chimeric antigen receptors (CARs), allowing them to target and destroy cancer cells with precision. While gene therapies for cancer are still evolving, they represent a promising avenue for personalized and targeted treatment approaches, potentially revolutionizing cancer care by addressing the genetic basis of the disease. Ongoing research and clinical trials continue to explore and refine these therapeutic strategies.
The major global suppliers of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics, Ziopharm Oncology, Anchiano Therapeutics, Celsion, Celgene, Bluebird Bio, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gene Therapies for Cancer Treatment. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Gene Therapies for Cancer Treatment market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gene Therapies for Cancer Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapies for Cancer Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Gene Therapies for Cancer Treatment Include:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celsion
Celgene
Bluebird Bio
Gene Therapies for Cancer Treatment Product Segment Include:
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Gene Therapies for Cancer Treatment Product Application Include:
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gene Therapies for Cancer Treatment Industry PESTEL Analysis
Chapter 3: Global Gene Therapies for Cancer Treatment Industry Porter's Five Forces Analysis
Chapter 4: Global Gene Therapies for Cancer Treatment Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Gene Therapies for Cancer Treatment Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Gene Therapies for Cancer Treatment Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gene Therapies for Cancer Treatment Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Gene Therapies for Cancer Treatment market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Gene Therapies for Cancer Treatment market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Gene therapies for cancer treatment involve the introduction or modification of genetic material within a patient＇s cells to target and combat cancer. This innovative approach aims to address underlying genetic abnormalities responsible for the development and progression of cancer. Various strategies are employed, including introducing therapeutic genes, modifying existing genes, or utilizing gene editing technologies to enhance the body＇s ability to recognize and eliminate cancer cells. One prominent example involves using viral vectors to deliver therapeutic genes that instruct the immune system to recognize and attack cancer cells specifically. CAR-T cell therapy is a notable gene therapy for certain blood cancers, where a patient＇s T cells are engineered to express chimeric antigen receptors (CARs), allowing them to target and destroy cancer cells with precision. While gene therapies for cancer are still evolving, they represent a promising avenue for personalized and targeted treatment approaches, potentially revolutionizing cancer care by addressing the genetic basis of the disease. Ongoing research and clinical trials continue to explore and refine these therapeutic strategies.
The major global suppliers of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics, Ziopharm Oncology, Anchiano Therapeutics, Celsion, Celgene, Bluebird Bio, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gene Therapies for Cancer Treatment. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Gene Therapies for Cancer Treatment market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gene Therapies for Cancer Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapies for Cancer Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Gene Therapies for Cancer Treatment Include:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celsion
Celgene
Bluebird Bio
Gene Therapies for Cancer Treatment Product Segment Include:
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Gene Therapies for Cancer Treatment Product Application Include:
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gene Therapies for Cancer Treatment Industry PESTEL Analysis
Chapter 3: Global Gene Therapies for Cancer Treatment Industry Porter's Five Forces Analysis
Chapter 4: Global Gene Therapies for Cancer Treatment Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Gene Therapies for Cancer Treatment Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Gene Therapies for Cancer Treatment Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gene Therapies for Cancer Treatment Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Gene Therapies for Cancer Treatment Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gene Therapies for Cancer Treatment Product by Type
- 1.2.1 Somatic Cell Gene Therapy (SCGT)
- 1.2.2 Germline Gene Therapy (GGT)
- 1.3 Gene Therapies for Cancer Treatment Product by Application
- 1.3.1 Cancer Research Centers
- 1.3.2 Diagnostic Laboratories
- 1.3.3 Cancer Hospitals
- 1.3.4 Others
- 1.4 Global Gene Therapies for Cancer Treatment Market Size Analysis (2020-2032)
- 1.5 Gene Therapies for Cancer Treatment Market Development Status and Trends
- 1.5.1 Gene Therapies for Cancer Treatment Industry Development Status Analysis
- 1.5.2 Gene Therapies for Cancer Treatment Industry Development Trends Analysis
- 2 Gene Therapies for Cancer Treatment Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gene Therapies for Cancer Treatment Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gene Therapies for Cancer Treatment Market Analysis by Country
- 4.1 Global Gene Therapies for Cancer Treatment Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Gene Therapies for Cancer Treatment Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Gene Therapies for Cancer Treatment Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.5 China Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.6 France Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.14 India Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Gene Therapies for Cancer Treatment Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Gene Therapies for Cancer Treatment Market Revenue by Key Suppliers (2021-2025)
- 5.2 Gene Therapies for Cancer Treatment Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Gene Therapies for Cancer Treatment Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Gene Therapies for Cancer Treatment Market Analysis by Type
- 6.1 Global Gene Therapies for Cancer Treatment Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Gene Therapies for Cancer Treatment Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Takara Bio
- 7.1.1 Takara Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Takara Bio Gene Therapies for Cancer Treatment Product Portfolio
- 7.1.3 Takara Bio Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Tocagen
- 7.2.1 Tocagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Tocagen Gene Therapies for Cancer Treatment Product Portfolio
- 7.2.3 Tocagen Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 VBL Therapeutics
- 7.3.1 VBL Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 VBL Therapeutics Gene Therapies for Cancer Treatment Product Portfolio
- 7.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Cold Genesys
- 7.4.1 Cold Genesys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Cold Genesys Gene Therapies for Cancer Treatment Product Portfolio
- 7.4.3 Cold Genesys Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Genprex
- 7.5.1 Genprex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Genprex Gene Therapies for Cancer Treatment Product Portfolio
- 7.5.3 Genprex Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Momotaro-Gene
- 7.6.1 Momotaro-Gene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Momotaro-Gene Gene Therapies for Cancer Treatment Product Portfolio
- 7.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 MultiVir
- 7.7.1 MultiVir Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 MultiVir Gene Therapies for Cancer Treatment Product Portfolio
- 7.7.3 MultiVir Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 SynerGene Therapeutics
- 7.8.1 SynerGene Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 SynerGene Therapeutics Gene Therapies for Cancer Treatment Product Portfolio
- 7.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Ziopharm Oncology
- 7.9.1 Ziopharm Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Ziopharm Oncology Gene Therapies for Cancer Treatment Product Portfolio
- 7.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Anchiano Therapeutics
- 7.10.1 Anchiano Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Anchiano Therapeutics Gene Therapies for Cancer Treatment Product Portfolio
- 7.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Celsion
- 7.11.1 Celsion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Celsion Gene Therapies for Cancer Treatment Product Portfolio
- 7.11.3 Celsion Gene Therapies for Cancer Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Celgene
- 7.12.1 Celgene Basic Company Profile (Employees, Areas Service, Compet
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
